Site-specific acetylation of polynucleotide kinase 3'-phosphatase regulates its distinct role in DNA repair pathways.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
21 Mar 2024
Historique:
accepted: 01 01 2024
revised: 21 12 2023
received: 05 09 2023
pubmed: 15 1 2024
medline: 15 1 2024
entrez: 15 1 2024
Statut: ppublish

Résumé

Mammalian polynucleotide kinase 3'-phosphatase (PNKP), a DNA end-processing enzyme with 3'-phosphatase and 5'-kinase activities, is involved in multiple DNA repair pathways, including base excision (BER), single-strand break (SSBR), and double-strand break repair (DSBR). However, little is known as to how PNKP functions in such diverse repair processes. Here we report that PNKP is acetylated at K142 (AcK142) by p300 constitutively but at K226 (AcK226) by CBP, only after DSB induction. Co-immunoprecipitation analysis using AcK142 or AcK226 PNKP-specific antibodies showed that AcK142-PNKP associates only with BER/SSBR, and AcK226 PNKP with DSBR proteins. Despite the modest effect of acetylation on PNKP's enzymatic activity in vitro, cells expressing non-acetylable PNKP (K142R or K226R) accumulated DNA damage in transcribed genes. Intriguingly, in striatal neuronal cells of a Huntington's Disease (HD)-based mouse model, K142, but not K226, was acetylated. This is consistent with the reported degradation of CBP, but not p300, in HD cells. Moreover, transcribed genomes of HD cells progressively accumulated DSBs. Chromatin-immunoprecipitation analysis demonstrated the association of Ac-PNKP with the transcribed genes, consistent with PNKP's role in transcription-coupled repair. Thus, our findings demonstrate that acetylation at two lysine residues, located in different domains of PNKP, regulates its distinct role in BER/SSBR versus DSBR.

Identifiants

pubmed: 38224455
pii: 7547335
doi: 10.1093/nar/gkae002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2416-2433

Subventions

Organisme : NIH HHS
ID : 2R01 NS073976
Pays : United States
Organisme : NIAID NIH HHS
ID : AI062885
Pays : United States
Organisme : NIH HHS
ID : 2R01 NS073976
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.

Auteurs

Azharul Islam (A)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

Anirban Chakraborty (A)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

Altaf H Sarker (AH)

Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.

Uma K Aryal (UK)

Purdue Proteomics Facility, Bindley Bioscience Center, Purdue University, IN 47907, USA.

Lang Pan (L)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Gulshan Sharma (G)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

Istvan Boldogh (I)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Tapas Hazra (T)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.

Classifications MeSH